GlassScriptPhysician profile
John Paul Prodromo
NPI 1760821433
$16,958.60
in general payments reported to CMS, 2019-2025
14 companies · $2,990 in 2025
The $2,990 reported for 2025 was more than what 76% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,476 · 2020: $1,183 · 2021: $107 · 2022: $45.40 · 2023: $1,294 · 2024: $5,863 · 2025: $2,990.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $4,225 · Travel and Lodging: $3,850 · Food and Beverage: $2,072.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $4,225.00 |
| Travel and Lodging | $3,850.30 |
| Food and Beverage | $2,071.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $7,410.92 | 2019-2025 | |
| Vericel Corporation | $4,275.95 | 2019-2024 | Maci |
| Seapearl East, INC | $3,342.70 | 2020-2025 | |
| Stryker Corporation | $513.33 | 2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform, Aequalis Perform Reversed |
| Encore Medical, LP | $321.85 | 2019-2020 | |
| Medical Device Business Services, INC. | $207.89 | 2020-2023 | |
| Coastal Medical Technologies LLC | $197.85 | 2025 | |
| Mid-Atlantic Surgical Systems, LLC | $181.02 | 2025 | |
| Depuy Synthes Sales INC. | $117.88 | 2019 | |
| Pacira Therapeutics, INC. | $114.91 | 2020-2021 | |
| Bioventus LLC | $95.74 | 2021-2024 | Durolane |
| Smith+Nephew, INC. | $84.28 | 2019 | |
| Wright Medical Technology, INC. | $53.74 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $40.54 | 2019-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Prodromo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.